To include your compound in the COVID-19 Resource Center, submit it here.

LE-T topical formulation of Lotemax etabonate steroid with tobramycin antibiotic regulatory update

BOL said the FDA accepted for review

Read the full 74 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE